Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS30011016HIVENSG00000001626.18protein_codingCFTRNoNo1080P13569
TVIS30088012HIVENSG00000001626.18protein_codingCFTRNoNo1080P13569
TVIS30086818HIVENSG00000001626.18protein_codingCFTRNoNo1080P13569
TVIS30076758HIVENSG00000001626.18protein_codingCFTRNoNo1080P13569
TVIS30077839HIVENSG00000001626.18protein_codingCFTRNoNo1080P13569
TVIS30067852HIVENSG00000001626.18protein_codingCFTRNoNo1080P13569
TVIS30067853HIVENSG00000001626.18protein_codingCFTRNoNo1080P13569
TVIS30067854HIVENSG00000001626.18protein_codingCFTRNoNo1080P13569
TVIS30067855HIVENSG00000001626.18protein_codingCFTRNoNo1080P13569
TVIS30067856HIVENSG00000001626.18protein_codingCFTRNoNo1080P13569
TCGA Plot Options
Drug Information
GeneCFTR
DrugBank IDDB11712
Drug NameTezacaftor
Target IDBE0001195
UniProt IDP13569
Regulation Typepositive allosteric modulator
PubMed IDs28930490; 29099344; 27714410
CitationsDonaldson SH, Pilewski JM, Griese M, Cooke J, Viswanathan L, Tullis E, Davies JC, Lekstrom-Himes JA, Wang LT: Tezacaftor/Ivacaftor in Subjects with Cystic Fibrosis and F508del/F508del-CFTR or F508del/G551D-CFTR. Am J Respir Crit Care Med. 2018 Jan 15;197(2):214-224. doi: 10.1164/rccm.201704-0717OC.@@Taylor-Cousar JL, Munck A, McKone EF, van der Ent CK, Moeller A, Simard C, Wang LT, Ingenito EP, McKee C, Lu Y, Lekstrom-Himes J, Elborn JS: Tezacaftor-Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508del. N Engl J Med. 2017 Nov 23;377(21):2013-2023. doi: 10.1056/NEJMoa1709846. Epub 2017 Nov 3.@@Saint-Criq V, Gray MA: Role of CFTR in epithelial physiology. Cell Mol Life Sci. 2017 Jan;74(1):93-115. doi: 10.1007/s00018-016-2391-y. Epub 2016 Oct 6.
GroupsApproved; Investigational
Direct ClassificationN-alkylindoles
SMILESCC(C)(CO)C1=CC2=CC(NC(=O)C3(CC3)C3=CC=C4OC(F)(F)OC4=C3)=C(F)C=C2N1C[C@@H](O)CO
Pathways
PharmGKB
ChEMBLCHEMBL3544914